SEVEN EIGHT CAPITAL, LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$311,869
-71.3%
5,481
-80.0%
0.08%
-62.7%
Q3 2022$1,086,000
+90.9%
27,459
+112.3%
0.22%
-5.2%
Q2 2022$569,000
-10.1%
12,937
-16.9%
0.23%
+275.4%
Q3 2021$633,000
+213.4%
15,566
+228.5%
0.06%
+32.6%
Q1 2021$202,0000.0%4,7390.0%0.05%0.0%
Q4 2020$202,000
-36.7%
4,739
-61.0%
0.05%
-33.3%
Q3 2020$319,000
+45.0%
12,139
+48.1%
0.07%
-57.1%
Q2 2020$220,000
+3042.9%
8,196
+1539.2%
0.16%
+2583.3%
Q3 2015$7,000
+250.0%
500
+400.0%
0.01%
+200.0%
Q2 2015$2,0001000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders